Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human P2Y2 ELISA Kit (AC2450)
Cat.#: ASET-1039
Specifications
Description Human P2Y2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human P2Y2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.24 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2098 Human LCN1 ELISA Kit (AC3509) Quantitative inquiry ASET-2289 Rat Dehydroepiandrosterone ELISA Kit (AC3700) Quantitative inquiry ASET-2466 Human OLFML2B ELISA Kit (AC3877) Quantitative inquiry ASET-2105 Human GRK2 ELISA Kit (AC3516) Quantitative inquiry ASET-1621 Mouse PPAR gamma ELISA Kit (AC3032) Quantitative inquiry ASET-2425 Human DYRK1A ELISA Kit (AC3836) Quantitative inquiry ASET-1859 Human G-Protein Coupled Receptor 30 ELISA Kit (AC3270) Quantitative inquiry ASET-1975 Human SOX6 ELISA Kit (AC3386) Quantitative inquiry ASET-1750 Human alpha Synuclein ELISA Kit (AC3161) Quantitative inquiry ASET-2115 Mouse ERK2 ELISA Kit (AC3526) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket